Latest Bare-metal stent Stories
WALTHAM, Mass., May 5 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, when Abbott Vascular's Xience V and Boston Scientific's Promus entered the Japanese drug-eluting stent market in Q1 2010, both companies picked up share from competitors Medtronic and Cordis. In its peak sales month, Xience V was used in over 50% of drug-eluting stent procedures, and averaged a unit share of just less than 40% for the first...
Patients who can postpone non-cardiac surgery for at least six weeks after receiving a coronary stent are less likely to suffer reduced blood flow to the heart, heart attack and death than those who have surgery sooner.
NATICK, Mass., March 10 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements at the 59th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 13-16 in Atlanta.
DALLAS, Feb. 11 /PRNewswire-USNewswire/ -- Volunteers and staff of the American Heart Association extend their thoughts and well wishes to former President Bill Clinton upon the reports that he has undergone a procedure to insert stents to widen narrowed coronary arteries.
NEW YORK, Dec.
NEW YORK, Dec.
NEW YORK, Nov.
- A person in a secondary role, specifically the second most important character (after the protagonist).